ctrl K

AI Score

Unlock

Prelude Therapeutics (PRLD)

AI Score

Unlock

0.71

-0.05 (-6.46%)

At close: Mar 03, 2025, 3:59 PM

0.68

-3.25%

After-hours: Mar 03, 2025, 04:00 PM EST

Prelude Therapeutics Balance Sheet Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Cash & Equivalents	25.29M	30.61M	31.83M	218.31M	18.88M	15.6M
Short-Term Investments	207.64M	171.12M	259.4M	n/a	n/a	n/a
Long-Term Investments	n/a	4.04M	4.04M	n/a	n/a	n/a
Other Long-Term Assets	4.34M	5.38M	303K	301K	n/a	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	2.65M	2.65M	7.76M	5M	1.34M	n/a
Total Current Assets	235.59M	204.38M	295.12M	220.81M	20.22M	15.6M
Property-Plant & Equipment	37.74M	6.7M	5.64M	2.48M	1.65M	811K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	42.08M	16.12M	9.98M	2.78M	1.65M	811K
Total Assets	277.67M	220.5M	305.1M	223.59M	21.87M	16.41M
Account Payables	4.58M	6.78M	7.84M	3.92M	1.97M	1.36M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	1.48M	3.66M	3.48M	n/a	258K	n/a
Other Current Liabilities	15.77M	11.26M	7.88M	7.46M	2.6M	1.08M
Total Current Liabilities	21.83M	21.7M	19.2M	11.38M	4.83M	2.45M
Long-Term Debt	15.41M	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	3.34M	3.36M	n/a	32K	66.45M	36.65M
Total Long-Term Liabilities	18.75M	3.36M	n/a	32K	66.45M	36.65M
Total Liabilities	40.58M	25.06M	19.2M	11.41M	71.28M	39.1M
Total Debt	16.89M	1.83M	1.74M	n/a	258K	n/a
Common Stock	5K	5K	5K	4K	n/a	n/a
Retained Earnings	-456.39M	-334.56M	-219.12M	-107.43M	-50.5M	-22.93M
Comprehensive Income	223K	-1.69M	-711K	-223.59M	n/a	-191K
Shareholders Equity	237.09M	195.44M	285.9M	212.18M	-49.41M	-22.69M
Total Investments	207.64M	171.12M	259.4M	n/a	n/a	n/a